Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.06p
   
  • Change Today:
      2.85p
  • 52 Week High: 8.70p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 45,375,545
  • Market Cap: £40.28m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £119,970
Lisa Baderoon 583,963 £47,067
Tim Franklin 525,000 £42,315

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 44,945,948 £3,622,643
Luca & Associates AG 22,000,000 £1,773,200
Invesco Ltd 17,872,341 £1,440,511
Aviva Investors Global 11,285,180 £909,586
Alora Pharmaceuticals LLC 10,909,091 £879,273
M&G Investments 7,600,000 £612,560
Prudential plc 7,600,000 £612,560
Capital Income Builder 4,870,367 £392,552
Dr R Zimmer 4,551,553 £366,855
Odey Asset Management 3,433,319 £276,726
Rhone Trustees (Switzerland) SA 3,386,000 £272,912
Pictet Overseas Trust Corporation Limited 3,287,500 £264,972

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 8.06p
Change Today 2.85p
% Change 54.70 %
52 Week High 8.70p
52 Week Low 1.09p
Volume 45,375,545
Shares Issued 499.72m
Market Cap £40.28m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 08-Sep-2025

Time Volume / Share Price
16:27 250,000 @ 8.10p
16:25 250,000 @ 7.85p
15:48 245,692 @ 7.65p
15:20 185,619 @ 8.20p
16:04 131,836 @ 7.58p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page